The Generic Drug User Fee Amendments (GDUFA): Background and Reauthorization

Research ReportCRS ReportVersion 3

R46778

The Generic Drug User Fee Amendments (GDUFA): Background and Reauthorization

Published Apr 29, 2021Updated Jun 21, 2025

Full report

What this is

The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.

Read the PDF on Congress.gov

HR 2430115th Congress
FDA Reauthorization Act of 2017
Aug 18, 2017 · Signed by President.

The Generic Drug User Fee Amendments (GDUFA): Background and Reauthorization

Legislation this report covers